Curtiss-Wright (CW) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jan, 2026Executive summary
Q1 2025 sales reached $806 million, up 13% year-over-year, with all segments contributing to growth and strong performance in aerospace, defense, and commercial markets.
Operating income rose 34% to $134 million, with margin expansion of 260 basis points, and net earnings increased 32% to $101 million.
Diluted EPS increased 42% to $2.82, with adjusted EPS up 42% and basic EPS up 35% to $2.68.
Record new orders of $1.0 billion, up 13%, with a book-to-bill ratio of 1.26x and backlog exceeding $3.6 billion.
Raised full-year 2025 guidance for sales, operating margins, and EPS, reflecting confidence in continued growth.
Financial highlights
Q1 2025 sales were $806 million, up from $713 million in Q1 2024 (+13%), with 11% organic growth.
Adjusted operating income was $134 million (+34%), with company-wide margin expanding to 16.6% from 14.0%.
Diluted EPS was $2.82, up 42% year-over-year; net earnings were $101 million, up from $76 million.
Free cash flow was negative $55 million, a 5% improvement year-over-year, with FCF conversion expected to exceed 105% for 2025.
Book-to-bill ratio was 1.26, with backlog at $3.7 billion, up 7% since year-end.
Outlook and guidance
Full-year 2025 sales guidance raised to $3.365–$3.415 billion, up 8–9%, with 5–7% organic growth.
Operating margin guidance increased to 18.3%–18.5%, up 80–100 basis points.
Diluted EPS projected at $12.45–$12.80, up 14–17% year-over-year.
Free cash flow guidance increased to $495–$515 million, with capex up nearly $20 million and FCF conversion >105%.
Guidance incorporates potential direct impacts from tariffs and mitigating actions.
Latest events from Curtiss-Wright
- Record 2025 growth and strong 2026 outlook driven by margin expansion and robust demand.CW
Q4 202512 Feb 2026 - Strong growth, margin expansion, and new mandates drive momentum across defense, aerospace, and nuclear.CW
18th Annual Global Transportation & Industrials Conference3 Feb 2026 - Q2 sales up 11%, adjusted EPS up 24%, record backlog, and 2024 guidance raised.CW
Q2 20242 Feb 2026 - Poised for rapid growth, especially in commercial nuclear and SMRs, through innovation and strategic acquisitions.CW
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Margin expansion, innovation, and nuclear growth position the business for long-term value creation.CW
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Pivot to Growth strategy drives strong revenue, margin expansion, and future-ready investments.CW
Jefferies Global Industrial Conference 202422 Jan 2026 - New three-year targets leverage R&D, nuclear growth, and defense alignment for sustained expansion.CW
Morgan Stanley 12th Annual Laguna Conference20 Jan 2026 - Q3 2024 delivered 10% sales growth, record backlog, and higher full-year guidance.CW
Q3 202417 Jan 2026 - Nuclear and defense growth, margin expansion, and robust cash flow drive ambitious targets.CW
Baird 2024 Global Industrials Conference13 Jan 2026